Tusk Innovation Announces New Products Black Friday
17.11.2022 11:06:00 EET | Business Wire | Press release
Tusk Inc. Limited (www.tusklimited.com) a company which started in 2012 as a capital management company in Kuala Lumpur with offices around the world, and now is one of the leading electrical solution companies which focus on producing for users of mining equipment, solar energy and adapters is announcing is announcing new products for Black Friday. The Product line is mainly for electrical purposes. See more here https://tusklimited.com/products
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221116005532/en/
This product is sold with a 7in 1 Solar Panel, so you don’t have to pay for the panel. (Photo: Business Wire)
As one of the top Electrical solution companies, Tusk innovation has announced 30% Black Friday discounts on its combo of mining equipment, which combines a solar panel with a bitcoin miner. They do this to enable uninterrupted mining without a connection to any significant electricity, as electricity has been a major issue in the mining industry.
With their recent movement from polycrystalline to photovoltaic materials, Tusk innovation has tested over time the efficiency of combining their solar products with cryptocurrency miners, and this has proven to be the most effective. Tusk innovation investors can now with ease, mine their coins without interruptions, lesser risks and maximum profit.
This is an effort to reduce the amount of electricity used when clients mine cryptocurrencies, and it was disclosed by the COO, John Walls, last week. According to Walls, "Reports going around made it evident that the quantity of electricity miners require may be too large to handle, therefore we obtained a plausible option."
Mining Profits
Although it is admirable and highly profitable for many people to set up cryptocurrency mining farms, speculations are rife that they may incur significant costs, particularly in terms of electricity use. By providing you with a Solar Panel that is unconnected to your electricity bills and a bitcoin mining device that can perform dual mining tasks, Tusk Inc has created a long-lasting solution. You can simply mine your coins and not bother about the market's volatility.
Located in the heart of Kuala Lumpur, Malaysia, and United Kingdom, Tusk Inc has distinguished itself from others, in that customers can get crypto wallet development services as well as graphics processing units from the company, which has offices on three continents. It also has extensive experience in Blockchain development and bitcoin mining solutions, among other areas.
About Tusk
Established in 2012 by team of management experts, and later joined by a team of technology experts, Tusk Inc is now one of the leading electrical solution providers. They pride themselves also in their ability to manage risk effectively, since they have been in the business of managing risks for over a decade. And through several advancements in technology, they have incorporated less risky ventures into the Risk Management system, one of which is cryptocurrency mining, using photovoltaic materials.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005532/en/
Contact information
John Walls
PR Manager
john@tusklimited.com
(+60)1117000943
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release
Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila
PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom